日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium

elranatamab治疗多发性骨髓瘤的真实世界疗效:来自美国多发性骨髓瘤免疫治疗联盟的多中心分析

Portuguese, Andrew J; Davis, James A; Raza, Shahzad; Castaneda Puglianini, Omar; Freeman, Ciara; Alsina, Melissa; Wright, Corbin; Blue, Brandon J; Baz, Rachid C; Shain, Kenneth H; Goel, Utkarsh; Khouri, Jack; Anwer, Faiz; Ali, Hossam M; Pasvolsky, Oren; Gaballa, Mahmoud; Patel, Krina; Garcia-Pleitez, Hector; Mikulski, Damian; Fogel, Lindsay; Zolotov, Eli; Sannareddy, Aishwarya; Afrough, Aimaz; Anderson, Larry D Jr; Julian, Kelley; Dima, Danai; Banerjee, Rahul; Liang, Emily C; Cassano Cassano, Raffaella; Herr, Megan M; Hassan, Hamza; Shune, Leyla; Kort, Jeries; Midha, Shonali; Nadeem, Omar; Sidana, Surbhi; Lin, Yi; Locke, Frederick L; Hansen, Doris K; Sborov, Douglas; Biran, Noa; Grajales-Cruz, Ariel

Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial

Axicabtagene Ciloleucel联合Atezolizumab治疗难治性弥漫性大B细胞淋巴瘤患者:1/2期ZUMA-6试验

Jacobson, Caron A; Westin, Jason R; Miklos, David B; Herrera, Alex F; Ritz, Jerome; Rodig, Scott; Arihara, Yohei; Cao, Subing; Sun, Jennifer; Mao, Daqin; Adhikary, Sabina; Neumann, Frank; Grechko, Nikolay; Locke, Frederick L

Cytopenias and infections following ciltacabtagene autoleucel in heavily pretreated relapsed or refractory multiple myeloma

在接受过大量预处理的复发或难治性多发性骨髓瘤患者中,使用ciltacabtagene autoleucel治疗后出现细胞减少症和感染

Dima, Danai; Logue, Jennifer M; Waqar, Syed Hamza Bin; Peres, Lauren C; Colin-Leitzinger, Christelle M; De Avila, Gabriel; Smith, Eric C; Skelson, Lawrence; Matte, Kristy L; Blue, Brandon; Hovanky, Vanna N; Gaballa, Mahmoud; Pasvolsky, Oren; Oswald, Laura B; Fortuna, Gliceida Galarza M; Wagner, Charlotte B; DeJarnette, Shaun; Dillard, Christen; Perna, Fabiana; Mikkilineni, Lekha; Hosoya, Hitomi; Freeman, Ciara L; Shain, Kenneth H; Baz, Rachid C; Grajales-Cruz, Ariel; Puglianini, Omar Castaneda; Alsina, Melissa; Locke, Frederick L; Shune, Leyla O; Sborov, Douglas W; Patel, Krina K; Sidana, Surbhi; Hansen, Doris K

Racial and clinical determinants of response in 2304 large B-cell lymphomas treated with CD19 CAR T in clinical trials

临床试验中 2304 例接受 CD19 CAR-T 治疗的大 B 细胞淋巴瘤患者的种族和临床反应决定因素

Kho, Soon Jye; Diamond, Sheila; Lafeuille, Penelope; Schatz, Jonathan H; Maura, Francesco; Aptekar, Jacob; Locke, Frederick L

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

嵌合抗原受体T细胞疗法治疗大B细胞淋巴瘤后生存率相关的新合并症指数

Greenbaum, Uri; Hashmi, Hamza; Elsawy, Mahmoud; Kim, Soyoung; Moskop, Amy; Oloyede, Temitope; Awan, Farrukh T; Bachanova, Veronika; Badar, Talha; Bar, Merav; Barba, Pere; Beitinjaneh, Amer M; Cashen, Amanda; Dholaria, Bhagirathbhai; Farooq, Umar; Foglesong, Jessica; Ganguly, Siddhartha; Hematti, Peiman; Hill, LaQuisa C; Jain, Michael D; Jain, Tania; Kebriaei, Partow; Kittai, Adam S; Locke, Frederick L; Lulla, Premal D; McGuirk, Joseph P; Mead, Elena; Mussetti, Alberto; Nishihori, Taiga; Olson, Amanda L; Pennisi, Martina; Perales, Miguel-Angel; Geethakumari, Praveen Ramakrishnan; Riedell, Peter A; Saber, Wael; Shouval, Roni; Shpall, Elizabeth J; Magalhaes-Silverman, Margarida; Strouse, Christopher; Turtle, Cameron J; Vallurupalli, Anusha; Wudhikarn, Kitsada; Pasquini, Marcelo C; Ahmed, Sairah; Sorror, Mohamed

Meaningful change in patient-reported outcomes after CAR-T for multiple myeloma: differences by race and ethnicity

CAR-T疗法治疗多发性骨髓瘤后,患者报告结局发生显著变化:种族和民族差异

Oswald, Laura B; Li, Xiaoyin; Ferraris, Carina E; De Avila, Gabe; Scheiber-Camoretti, David; Gudenkauf, Lisa M; Small, Brent J; Gonzalez, Brian D; Hoogland, Aasha I; Nguyen, Oanh; Rodriguez, Yvelise; Crowder, Sylvia L; Parker, Nathan; Carson, Tiffany L; Vinci, Christine E; Baz, Rachid C; Shain, Kenneth H; Blue, Brandon; Grajales-Cruz, Ariel F; Matte, Kristy; Kale, Brandon; Kaldas, David; Perna, Fabiana; Alsina, Melissa; Freeman, Ciara L; Castaneda Puglianini, Omar; Nishihori, Taiga; Liu, Hien; Locke, Frederick L; Jim, Heather S L; Hansen, Doris K; Peres, Lauren C

A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma

一种用于预测复发/难治性淋巴瘤患者接受 CAR-T 细胞治疗后严重免疫相关不良事件的循环蛋白特征

Irajizad, Ehsan; Fahrmann, Johannes F; Katayama, Hiroyuki; Strati, Paolo; Nair, Ranjit; Chihara, Dai; Fayad, Luis E; Ahmed, Sairah; Iyer, Swaminathan P; Wang, Michael; Locke, Frederick L; Davila, Marco; Flowers, Christopher R; Shpall, Elizabeth; Neelapu, Sattva S; Hanash, Samir; Westin, Jason; Jain, Michael D; John, Teny M; Saini, Neeraj Y

Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas

Tisagenlecleucel联合ibrutinib治疗复发和/或难治性大B细胞淋巴瘤成人患者

Chavez, Julio C; Napier, Ellen; Bondanza, Attilio; Lewandowski, Andrew; Mataraza, Jennifer; Quinn, David; Kwon, Paul; Locke, Frederick L; Engels, Boris; Awasthi, Rakesh; Georgala, Petrina; Leyk, Malgorzata; Hynds, David; Moschetta, Michele; Schuster, Stephen J

BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials

BASECAMP-1 筛选研究:精准肿瘤临床试验高效入组的模式

Hecht, J Randolph; Molina, Julian R; Liechty, Kirstin; Welling, Theodore H; Grierson, Patrick M; Patel, Sandip P; Kirtane, Kedar; Morelli, M Pia; Locke, Frederick L; Maloney, David G; Punekar, Salman R; Nikiforow, Sarah; Lin, Yi; Ulrickson, Matthew; Specht, Jennifer M; Lozac'hmeur, Ariane; Osterman, Chelsea K; Garde, Ryan J; Rangel, Gena A; Ng, Eric W; Welch, John S; Tebbets, Jessica C; Go, William Y; Simeone, Diane M

Lymphoma accelerates T cell and tissue aging.

淋巴瘤会加速T细胞和组织的衰老。

Hesterberg Rebecca S, Davis Joshua T, Handoo Komal J, Elmarsafawi Aya G, Augello Anthony C, Cheng Chia-Ho, Atkins Reginald, Lee Dae Hyun, Yang Chunying, Yao Jiqiang, Patel Krishna R, Mediavilla-Varela Melanie, Pinilla-Ibarz Javier, Soto-Palma Carolina, Locke Frederick L, Song Xiaofei, Wang Xuefeng, Berglund Anders E, Rodriguez Paulo C, Knittel Gero, Flümann Ruth, Reinhardt Hans Christian, Shaw Timothy I, Yu Xiaoqing, Niedernhofer Laura J, Cleveland John L